Results 11 to 20 of about 65,270 (216)

Decompensation of chronic heart failure after COVID-19: a clinical observation

Клинический разбор в общей медицине, 2023
Chronic heart failure is a clinical syndrome that develops as a result of various diseases of both the cardiovascular and other systems, aggravates the course of the underlying disease, and increases the risk of an unfavorable outcome. The development of
Marina V. Moiseeva , Natalya V. Bagisheva, Anna V. Mordyk , Dmitry I. Trukhan, Victoria V. Streltsova, Irina I. Dubrovskaya   +5 more
doaj   +1 more source

Insulin-like growth factor 1 predicts decompensation and long-term prognosis in patients with compensated cirrhosis

Frontiers in Medicine, 2023
AimInsulin-like growth factor 1 (IGF-1), which is primarily produced in hepatocytes and is associated with liver functional reserve, plays a crucial role in the pathological condition of cirrhosis.
Chisato Saeki, Chisato Saeki, Tomoya Kanai, Tomoya Kanai, Kaoru Ueda, Masanori Nakano, Masanori Nakano, Tsunekazu Oikawa, Yuichi Torisu, Yuichi Torisu, Masayuki Saruta, Akihito Tsubota   +11 more
doaj   +1 more source

2020 Clinical practice guidelines for Chronic heart failure

Российский кардиологический журнал, 2020
Endorsed by the Research and Practical Council of the Ministry of Health of the Russian Federation.
. Russian Society of Cardiology (RSC)
doaj   +1 more source

BUSPIRONE HYDROCHLORIDE EFFECTS ON HOSPITALIZATIONS FREQUENCY IN PATIENTS WITH CHRONIC HEART FAILURE AND MIXED ANXIETY-DEPRESSIVE DISORDER

Архивъ внутренней медицины, 2017
Aim. Assessing the impact of buspirone hydrochloride on hospitalizations frequency in patients  with chronic heart failure (CHF) and mixed anxietydepressive disorder (MADD). Materials and methods.
M. A. Khristichenko
doaj   +1 more source

Mauriac syndrome in adult with type 1 diabetes mellitus

Сахарный диабет, 2011
We describe the case of Mauriac syndrome in young adult with prolonged poorly controlled type 1 diabetes mellitus.
Natalya Alexandrovna Molitvoslovova, Alla Yur'evna Tokmakova   +1 more
doaj   +1 more source

Corrigendum: Vulnerable period in heart failure: a window of opportunity for the optimization of treatment – a statement by Mexican experts

Drugs in Context
The authors wish to make the following corrections to their article: Magaña Serrano JA, Cigarroa López JA, Chávez Mendoza A, Ivey-Miranda JB, Mendoza Zavala GH, Olmos Domínguez L, Chávez Leal SA, Pombo Bartelt JE, Herrera-Garza EH, Mercado Leal G, Parra ...
José Antonio Magaña Serrano, José Angel Cigarroa López, Adolfo Chávez Mendoza, Juan Betuel Ivey-Miranda, Genaro Hiram Mendoza Zavala, Luis Olmos Domínguez, Sergio Armando Chávez Leal, José Ernesto Pombo Bartelt, Eduardo Heberto Herrera-Garza, Gerardo Mercado Leal, Rodolfo Parra Michel, Luisa Fernanda Aguilera Mora, Patricia Lenny Nuriulu Escobar   +12 more
doaj   +1 more source

Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitis

Hepatology, EarlyView., 2022
Adaptive mitochondrial mechanisms allow mitochondrial resilience and prevent the worsening of fibrosis, while deregulation of these mechanisms promotes the progression from no/minimal‐mild (F0‐F2) fibrosis to advanced fibrosis and cirrhosis (F3‐F4). Abstract Background and Aims Hepatitis B virus (HBV) infection causes oxidative stress (OS) and alters ...
Dimitri Loureiro, Issam Tout, Stéphanie Narguet, Cheikh Mohamed Bed, Morgane Roinard, Ahmad Sleiman, Nathalie Boyer, Nathalie Pons‐Kerjean, Corinne Castelnau, Nathalie Giuly, Dorothy Tonui, Vassili Soumelis, Jamel El Benna, Patrick Soussan, Richard Moreau, Valérie Paradis, Abdellah Mansouri, Tarik Asselah   +17 more
wiley   +1 more source

Janus kinase 2 inhibition by pacritinib as potential therapeutic target for liver fibrosis

Hepatology, EarlyView., 2022
Diagram of the activation of the profibrotic and procontractile Janus kinase 2 (JAK2)/Ras homolog family member A/Rho‐kinase pathway and the inhibition of phosphorylated JAK2 by pacritinib to inhibit hepatic stellate cell activity. Abstract Background and Aims Janus kinase 2 (JAK2) signaling is increased in human and experimental liver fibrosis with ...
Sandra Torres, Cristina Ortiz, Nadine Bachtler, Wenyi Gu, Leon D. Grünewald, Nico Kraus, Robert Schierwagen, Christoph Hieber, Caroline Meier, Olaf Tyc, Maximilian Joseph Brol, Frank Erhard Uschner, Bart Nijmeijer, Christoph Welsch, Marie‐Luise Berres, Carmen Garcia‐Ruiz, Jose Carlos Fernandez‐Checa, Christian Trautwein, Thomas J. Vogl, Stefan Zeuzem, Jonel Trebicka, Sabine Klein   +21 more
wiley   +1 more source

Hepatic Vessels Condition in Experimental Pulmonary Trunk Stenosis With Different Level of Blood Circulation Compensation [PDF]

Саратовский научно-медицинский журнал, 2009
Hepatic changes have been studied in 25 pupies with modeled stenosis with compensation and 8 animals with decompensated stenosis of pulmonary trunk. For controlling we have used liver of 10 dogs of the same age.
S.V. Kulikov
doaj  

Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis [PDF]

Clinical and Molecular Hepatology
Background/Aims Cirrhotic patients with liver stiffness measurement (LSM)
Haiyu Wang, Weihao Liang, Ling Zhou, Jiankang Song, Biao Wen, Qiaoping Wu, Yuanjian Zhang, Xiaofeng Zhang, Haoran Ke, Yujun Tang, Fuyuan Zhou, Youfu Zhu, Weiqun Wen, Zhihua Liu, Yali Ji, Qintao Lai, Qinjun He, Wenfan Luo, Tingting Qi, Miaoxia Liu, Xiaoqin Lan, Yongpeng Chen, Ranran Xi, Junting Wan, Lin Dai, Yuan Li, Jinjun Chen   +26 more
doaj   +1 more source